The FDA is con­tin­u­ing to rewind ac­tions by for­mer Com­mis­sion­er Mar­ty Makary, say­ing that two med­ical jour­nal ar­ti­cles pub­lished over the last year did not...

Law­mak­ers in the Sen­ate pressed the Trump ad­min­is­tra­tion’s nom­i­nee for CDC di­rec­tor on whether she will cave to po­lit­i­cal pres­sure dur­ing a con­fir­ma­tion hear­ing on...

John­son & John­son is an­tic­i­pat­ing as much as $750 mil­lion in costs to re­struc­ture its phar­ma­ceu­ti­cal sup­ply chain and ex­it fac­to­ries, moves that are com­ing...

Eli Lil­ly on Wednes­day made an eq­ui­ty in­vest­ment in wear­able ring start­up Oura as the drug­mak­er looks for ways to sup­port pa­tients tak­ing its GLP-1...

John­son & John­son teased some de­tails on Wednes­day morn­ing about how the launch of its ex­pect­ed block­buster Ico­tyde per­formed in the sec­ond quar­ter.

With­out dis­clos­ing...

A small pub­lic biotech won ap­proval for a breast can­cer drug that was de­signed to im­prove on sim­i­lar treat­ments from No­var­tis and Roche.

The FDA...